Ascendis gets boost from Remedica’s new tenders
The group’s crown-jewel asset secured new contracts and grew revenue 33% during the six months to end-September
05 February 2020 - 09:33
UPDATED 05 February 2020 - 17:17
Struggling health and wellness firm Ascendis Health, whose share price has lost more than a third of its value in 2020, said on Wednesday that it has been given a revenue boost by Cyprus-based Remedica, which it is still considering selling.
The group is grappling with a hefty debt burden, with its liabilities of R8.6bn as of the end of June exceeding its assets by R400m, an insufficient solvency ratio...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.